Bile salt activated lipase (CEL) Human shRNA Plasmid Kit (Locus ID 1056)
CAT#: TR313998
CEL - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 6,790.00
货期*
2周
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
Specifications
Product Data | |
Product Name | Bile salt activated lipase (CEL) Human shRNA Plasmid Kit (Locus ID 1056) |
Locus ID | 1056 |
Synonyms | BAL; BSDL; BSSL; CEase; CELL; FAP; FAPP; LIPA; MODY8 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | CEL - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 1056). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | BC042510, NM_001807, NM_001807.1, NM_001807.2, NM_001807.3, BC042510.1 |
Summary | The protein encoded by this gene is a glycoprotein secreted from the pancreas into the digestive tract and from the lactating mammary gland into human milk. The physiological role of this protein is in cholesterol and lipid-soluble vitamin ester hydrolysis and absorption. This encoded protein promotes large chylomicron production in the intestine. Also its presence in plasma suggests its interactions with cholesterol and oxidized lipoproteins to modulate the progression of atherosclerosis. In pancreatic tumoral cells, this encoded protein is thought to be sequestrated within the Golgi compartment and is probably not secreted. This gene contains a variable number of tandem repeat (VNTR) polymorphism in the coding region that may influence the function of the encoded protein. [provided by RefSeq, Jul 2008] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma
,Shen, J;Tsoi, H;Liang, Q;Chu, ES;Liu, D;Yu, AC;Chan, TF;Li, X;Sung, JJ;Wong, VW;Yu, J;,
Oncogene
,PubMed ID 27132506
[CEL]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...